Cargando…
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Metformin is a first-line drug for the treatment of individuals with type 2 diabetes, yet its precise mechanism of action remains unclear. Metformin exerts its anti-hyperglycemic action primarily through lowering of hepatic glucose production (HGP). This suppression is thought to be mediated through...
Autores principales: | Hunter, Roger W., Hughey, Curtis C., Lantier, Louise, Sundelin, Elias I., Peggie, Mark, Zeqiraj, Elton, Sicheri, Frank, Jessen, Niels, Wasserman, David H., Sakamoto, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207338/ https://www.ncbi.nlm.nih.gov/pubmed/30150719 http://dx.doi.org/10.1038/s41591-018-0159-7 |
Ejemplares similares
-
Expression and purification of functional human glycogen synthase-1:glycogenin-1 complex in insect cells
por: Hunter, Roger W., et al.
Publicado: (2015) -
Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1 kinase
por: Shehata, Saifeldin N., et al.
Publicado: (2012) -
Fructose 1,6-bisphosphatase: getting the message across
por: Timson, David J.
Publicado: (2019) -
Fructose-1, 6-bisphosphatase opposes renal carcinoma progression
por: Li, Bo, et al.
Publicado: (2014) -
Phosphofructokinase-1 and fructose bisphosphatase-1 in canine liver and
kidney
por: KANAI, Shuichiro, et al.
Publicado: (2019)